Genetic polymorphism at the 5′ regulatory region of multidrug resistance 1 (MDR1 ) and its association with interindividual variation of expression level in the colon

Molecular Cancer Therapeutics

Volumn 2, Issue 12, 2003, Pages 1351-1359

  Taniguchi, Shuichi ^a   Mochida, Yasushi ^a   Uchiumi, Takeshi ^a   Tahira, Tomoko ^b   Hayashi, Kenshi ^b   Takagi, Koichi ^c   Shimada, Mitsuo ^a   Maehara, Yoshihiko ^a   Kuwano, Hiroyuki ^d   Kono, Suminori ^a   Nakano, Hitoo ^a   Kuwano, Michihiko ^a,e   Wada, Morimasa ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

^c TAKANO HOSPITAL   (Japan)

^d GUNMA UNIVERSITY   (Japan)

^e Department of Medicine   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

PRIMER DNA;

ALLELE; ARTICLE; COLON; COLON TUMOR; GEL MOBILITY SHIFT ASSAY; GENE; GENETICS; HAPLOTYPE; HUMAN; INTESTINE MUCOSA; JAPAN; LIVER; METABOLISM; NUCLEOTIDE SEQUENCE; RECTUM; REGULATORY SEQUENCE; SINGLE NUCLEOTIDE POLYMORPHISM;

ALLELES; BASE SEQUENCE; COLON; COLONIC NEOPLASMS; DNA PRIMERS; ELECTROPHORETIC MOBILITY SHIFT ASSAY; GENES, MDR; HAPLOTYPES; HUMANS; INTESTINAL MUCOSA; JAPAN; LIVER; POLYMORPHISM, SINGLE NUCLEOTIDE; RECTUM; REGULATORY SEQUENCES, NUCLEIC ACID;

EID: 1942467691     PISSN: 15357163     EISSN: 15388514     Source Type: Journal    
DOI: None     Document Type: Article

References (51)

1. Roden, D. M. and George, A. L., Jr. The genetic basis of variability in drug responses. Nat. Rev. Drug Discov., 1: 37-44, 2002. (Pubitemid 37361402)
2. Evans, W. E. and Relling, M. V. Pharmacogenomics: translating functional genomics into rational therapeutics. Science, 286: 487-491, 1999.
3. Gonzalez, F. J., Skoda, R. C., Kimura, S., Umeno, M., Zanger, U. M., Nebert, D. W., Gelboin, H. V., Hardwick, J. P., and Meyer, U. A. Characterization of the common genetic defect in humans deficient in debrisoquine metabolism. Nature, 331: 442-446, 1988. (Pubitemid 18064368)
4. Konig, J., Nies, A. T., Cui, Y., Leier, I., and Keppler, D. Conjugate export pumps of the multidrug resistance protein (MRP) family: localization, substrate specificity, and MRP2-mediated drug resistance. Biochim. Biophys. Acta, 1461: 377-394, 1999.
5. Gottesman, M. M., Fojo, T., and Bates, S. E. Multidrug resistance in cancer: role of ATP-dependent transporters. Nat. Rev. Cancer, 2: 48-58, 2002. (Pubitemid 37328807)
6. Borst, P., Evers, R., Kool, M., and Wijnholds, J. A family of drug transporters: the multidrug resistance-associated proteins. J. Natl. Cancer Inst., 92: 1295-1302, 2000. (Pubitemid 30662093)
7. Holland, I. B., Cole, S. P. C., Kuchler, K., and Higgins, C. F. ABC Proteins, From Bacteria to Man, pp. 423 - 443. United Kingdom: Academic Press, 2003.
8. Wada, M., Uchiumi, T., and Kuwano, M. Canalicular multispecific organic anion transporter, ABCC2. In: S. Bröer and C. A. Wagner (eds.), Membrane Transport Diseases: Molecular Basis of Inherited Transport Defects. New York: Kluwer Academic/Plenum Publishers, 2003.
9. Kuwano, M., Uchiumi, T., Hayakawa, H., Ono, M., Wada, M., Izumi, H., and Kohno, K. The basic and clinical implications of ABC transporters, Y-box-binding protein-1 (YB-1) and angiogenesis-related factors in human malignancies. Cancer Sci., 94: 9-14, 2003. (Pubitemid 36575851)
10. Schinkel, A. H., Mayer, U., Wagenaar, E., Mol, C. A., van Deemter, L., Smit, J. J., van der Valk, M. A., Voordouw, A. C., Spits, H., van Tellingen, O., Zijlmans, J. M., Fibbe, W. E., and Borst, P. Normal viability and altered pharmacokinetics in mice lacking mdr1-type (drug-transporting) P-glycoproteins. Proc. Natl. Acad. Sci. USA, 94: 4028-4033, 1997. (Pubitemid 27180493)
11. Schinkel, A. H. Pharmacological insights from P-glycoprotein knockout mice. Int. J. Clin. Pharmacol. Ther., 36: 9-13, 1998. (Pubitemid 28031802)
12. Ambudkar, S. V., Dey, S., Hrycyna, C. A., Ramachandra, M., Pastan, I., and Gottesman, M. M. Biochemical, cellular, and pharmacological aspects of the multidrug transporter. Annu. Rev. Pharmacol. Toxicol., 39: 361-398, 1999. (Pubitemid 29222564)
13. Watkins, P. B. The barrier function of CYP3A4 and P-glycoprotein in the small bowel. Adv. Drug Deliv. Rev., 27: 161-170, 1997. (Pubitemid 27417871)
14. Fromm, M. F. The influence of MDR1 polymorphisms on P-glycoprotein expression and function in humans. Adv. Drug Deliv. Rev., 54: 1295-1310, 2002. (Pubitemid 35284254)
15. Scherf, U., Ross, D. T., Waltham, M., Smith, L. H., Lee, J. K., Tanabe, L., Kohn, K. W., Reinhold, W. C., Myers, T. G., Andrews, D. T., Scudiero, D. A., Eisen, M. B., Sausville, E. A., Pommier, Y., Botstein, D., Brown, P. O., and Weinstein, J. N. A gene expression database for the molecular pharmacology of cancer. Nat. Genet., 24: 236-244, 2000. (Pubitemid 30132190)
16. Fojo, A. T., Ueda, K., Slamon, D. J., Poplack, D. G., Gottesman, M. M., and Pastan, I. Expression of a multidrug-resistance gene in human tumors and tissues. Proc. Natl. Acad. Sci. USA, 84: 265-269, 1987.
17. Bargou, R. C., Jurchott, K., Wagener, C., Bergmann, S., Metzner, S., Bommert, K., Mapara, M. Y., Winzer, K. J., Dietel, M., Dorken, B., and Royer, H. D. Nuclear localization and increased levels of transcription factor YB-1 in primary human breast cancers are associated with intrinsic MDR1 gene expression. Nat. Med., 3: 447-450, 1997. (Pubitemid 27145688)
18. Ohga, T., Uchiumi, T., Makino, Y., Koike, K., Wada, M., Kuwano, M., and Kohno, K. Direct involvement of the Y-box binding protein YB-1 in genotoxic stress-induced activation of the human multidrug resistance 1 gene. J. Biol. Chem., 273: 5997-6000, 1998. (Pubitemid 28144673)
19. Harada, T., Nagayama, J., Kohno, K., Mickley, L. A., Fojo, T., Kuwano, M., and Wada, M. Alu-associated interstitial deletions and chromosomal re-arrangement in 2 human multidrug-resistant cell lines. Int. J. Cancer, 86: 506-511, 2000. (Pubitemid 30249730)
20. Kusaba, H., Nakayama, M., Harada, T., Nomoto, M., Kohno, K., Kuwano, M., and Wada, M. Association of 5′ CpG demethylation and altered chromatin structure in the promoter region with transcriptional activation of the multidrug resistance 1 gene in human cancer cells. Eur. J. Biochem., 262: 924-932, 1999. (Pubitemid 29291053)
21. Nakayama, M., Wada, M., Harada, T., Nagayama, J., Kusaba, H., Ohshima, K., Kozuru, M., Komatsu, H., Ueda, R., and Kuwano, M. Hypomethylation status of CpG sites at the promoter region and overexpression of the human MDR1 gene in acute myeloid leukemias. Blood, 92: 4296-4307, 1998. (Pubitemid 28544347)
22. Tada, Y., Wada, M., Kuroiwa, K., Kinugawa, N., Harada, T., Nagayama, J., Nakagawa, M., Naito, S., and Kuwano, M. MDR1 gene overexpression and altered degree of methylation at the promoter region in bladder cancer during chemotherapeutic treatment. Clin. Cancer Res., 6: 4618-4627, 2000. (Pubitemid 32110396)
23. Thiebaut, F., Tsuruo, T., Hamada, H., Gottesman, M. M., Pastan, I., and Willingham, M. C. Cellular localization of the multidrug-resistance gene product P-glycoprotein in normal human tissues. Proc. Natl. Acad. Sci. USA, 84: 7735-7738, 1987.
24. Sugawara, I., Kataoka, I., Morishita, Y., Hamada, H., Tsuruo, T., Itoyama, S., and Mori, S. Tissue distribution of P-glycoprotein encoded by a multidrug-resistant gene as revealed by a monoclonal antibody, MRK 16. Cancer Res., 48: 1926-1929, 1988.
25. Cordon-Cardo, C., O'Brien, J. P., Casals, D., Rittman-Grauer, L., Biedler, J. L., Melamed, M. R., and Bertino, J. R. Multidrug-resistance gene (P-glycoprotein) is expressed by endothelial cells at blood-brain barrier sites. Proc. Natl. Acad. Sci. USA, 86: 695-698, 1989. (Pubitemid 19037807)
26. Cordon-Cardo, C., O'Brien, J. P., Boccia, J., Casals, D., Bertino, J. R., and Melamed, M. R. Expression of the multidrug resistance gene product (P-glycoprotein) in human normal and tumor tissues. J. Histochem. Cytochem., 38: 1277-1287, 1990. (Pubitemid 20266126)
27. Schuetz, E. G., Schinkel, A. H., Relling, M. V., and Schuetz, J. D. P-glycoprotein: a major determinant of rifampicin-inducible expression of cytochrome P 4503A in mice and humans. Proc. Natl. Acad. Sci. USA, 93: 4001-4005, 1996. (Pubitemid 26144235)
28. Greiner, B., Eichelbaum, M., Fritz, P., Kreichgauer, H. P., von Richter, O., Zundler, J., and Kroemer, H. K. The role of intestinal P-glycoprotein in the interaction of digoxin and rifampin. J. Clin. Invest., 104: 147-153, 1999.
29. Schumacher, U. and Mollgard, K. The multidrug-resistance P-glycoprotein (Pgp, MDR1) is an early marker of blood-brain barrier development in the microvessels of the developing human brain. Histochem. Cell. Biol., 108: 179-182, 1997. (Pubitemid 27362344)
30. Rao, V. V., Dahlheimer, J. L., Bardgett, M. E., Snyder, A. Z., Finch, R. A., Sartorelli, A. C., and Piwnica-Worms, D. Choroid plexus epithelial expression of MDR1 P glycoprotein and multidrug resistance-associated protein contribute to the blood-cerebrospinal-fluid drug-permeability barrier. Proc. Natl. Acad. Sci. USA, 96: 3900-3905, 1999. (Pubitemid 29169008)
31. Thiebaut, F., Tsuruo, T., Hamada, H., Gottesman, M. M., Pastan, I., and Willingham, M. C. Immunohistochemical localization in normal tissues of different epitopes in the multidrug transport protein P170: evidence for localization in brain capillaries and crossreactivity of one antibody with a muscle protein. J. Histochem. Cytochem., 37: 159-164, 1989. (Pubitemid 19039163)
32. Hinoshita, E., Uchiumi, T., Taguchi, K., Kinukawa, N., Tsuneyoshi, M., Maehara, Y., Sugimachi, K., and Kuwano, M. Increased expression of an ATP-binding cassette superfamily transporter, multidrug resistance protein 2, in human colorectal carcinomas. Clin. Cancer Res., 6: 2401-2407, 2000. (Pubitemid 30399208)
33. Mochida, Y., Taguchi, K., Taniguchi, S., Tsuneyoshi, M., Kuwano, H., Tsuzuki, T., Kuwano, M., and Wada, M. The role of P-glycoprotein in intestinal tumorigenesis: disruption of mdr1a suppresses polyp formation in ApcMin/+ mice. Carcinogenesis, 24: 1219-1224, 2003. (Pubitemid 36927062)
34. Yamada, T., Mori, Y., Hayashi, R., Takada, M., Ino, Y., Naishiro, Y., Kondo, T., and Hirohashi, S. Suppression of intestinal polyposis in Mdr1-deficient ApcMin/+mice. Cancer Res., 63: 895-901, 2003. (Pubitemid 36278415)
35. Hoffmeyer, S., Burk, O., von Richter, O., Arnold, H. P., Brockmoller, J., Johne, A., Cascorbi, I., Gerloff, T., Roots, I., Eichelbaum, M., and Brinkmann, U. Functional polymorphisms of the human multidrug-resistance gene: multiple sequence variations and correlation of one allele with P-glycoprotein expression and activity in vivo. Proc. Natl. Acad. Sci. USA, 97: 3473-3478, 2000. (Pubitemid 30183327)
36. Ito, S., Ieiri, I., Tanabe, M., Suzuki, A., Higuchi, S., and Otsubo, K. Polymorphism of the ABC transporter genes, MDR1, MRP1 and MRP2/cMOAT, in healthy Japanese subjects. Pharmacogenetics, 11: 175-184, 2001. (Pubitemid 32216128)
37. Chen, C. J., Clark, D., Ueda, K., Pastan, I., Gottesman, M. M., and Roninson, I. B. Genomic organization of the human multidrug resistance (MDR1) gene and origin of P-glycoproteins. J. Biol. Chem., 265: 506-514, 1990.
38. Antonarakis, S. E. Recommendations for a nomenclature system for human gene mutations. Nomenclature Working Group. Hum. Mutat., 11: 1-3, 1998. (Pubitemid 128679142)
39. Gibson, U. E., Heid, C. A., and Williams, P. M. A novel method for real time quantitative RT-PCR. Genome Res., 6: 995-1001, 1996. (Pubitemid 26388092)
40. Andrews, N. C. and Faller, D. V. A rapid micropreparation technique for extraction of DNA-binding proteins from limiting numbers of mammalian cells. Nucleic Acids Res., 19: 2499, 1991.
41. Furukawa, M., Uchiumi, T., Nomoto, M., Takano, H., Morimoto, R. I., Naito, S., Kuwano, M., and Kohno, K. The role of an inverted CCAAT element in transcriptional activation of the human DNA topoisomerase IIα gene by heat shock. J. Biol. Chem., 273: 10550-10555, 1998. (Pubitemid 28227666)
42. Tanabe, M., Ieiri, I., Nagata, N., Inoue, K., Ito, S., Kanamori, Y., Takahashi, M., Kurata, Y., Kigawa, J., Higuchi, S., Terakawa, N., and Otsubo, K. Expression of P-glycoprotein in human placenta: relation to genetic polymorphism of the multidrug resistance (MDR)-1 gene. J. Pharmacol. Exp. Ther., 297: 1137-1143, 2001. (Pubitemid 32472514)
43. Kim, R. B., Leake, B. F., Choo, E. F., Dresser, G. K., Kubba, S. V., Schwarz, U. I., Taylor, A., Xie, H. G., McKinsey, J., Zhou, S., Lan, L. B., Schuetz, J. D., Schuetz, E. G., and Wilkinson, G. R. Identification of functionally variant MDR1 alleles among European Americans and African Americans. Clin. Pharmacol. Ther., 70: 189-199, 2001. (Pubitemid 32777772)
44. Horinouchi, M., Sakaeda, T., Nakamura, T., Morita, Y., Tamura, T., Aoyama, N., Kasuga, M., and Okumura, K. Significant genetic linkage of MDR1 polymorphisms at positions 3435 and 2677: functional relevance to pharmacokinetics of digoxin. Pharm. Res., 19: 1581-1585, 2002. (Pubitemid 35266567)
45. Nakamura, T., Sakaeda, T., Horinouchi, M., Tamura, T., Aoyama, N., Shirakawa, T., Matsuo, M., Kasuga, M., and Okumura, K. Effect of the mutation (C3435T) at exon 26 of the MDR1 gene on expression level of MDR1 messenger ribonucleic acid in duodenal enterocytes of healthy Japanese subjects. Clin. Pharmacol. Ther., 71: 297-303, 2002. (Pubitemid 34311459)
46. Goto, M., Masuda, S., Saito, H., Uemoto, S., Kiuchi, T., Tanaka, K., and Inui, K. C3435T polymorphism in the MDR1 gene affects the enterocyte expression level of CYP3A4 rather than Pgp in recipients of living-donor liver transplantation. Pharmacogenetics, 12: 451- 457, 2002.
47. Sakaeda, T., Nakamura, T., and Okumura, K. Pharmacogenetics of MDR1 and its impact on the pharmacokinetics and pharmacodynamics of drugs. Pharmacogenomics, 4: 397-410, 2003. (Pubitemid 36857176)
48. Esterbauer, H., Schneitler, C., Oberkofler, H., Ebenbichler, C., Paulweber, B., Sandhofer, F., Ladurner, G., Hell, E., Strosberg, A. D., Patsch, J. R., Krempler, F., and Patsch, W. A common polymorphism in the promoter of UCP2 is associated with decreased risk of obesity in middle-aged humans. Nat. Genet., 28: 178-183, 2001. (Pubitemid 32538066)
49. Ince, T. A. and Scotto, K. W. Stable transfection of the P-glycoprotein promoter reproduces the endogenous overexpression phenotype: the role of MED-1. Cancer Res., 56: 2021-2024, 1996. (Pubitemid 26119901)
50. Labialle, S., Gayet, L., Marthinet, E., Rigal, D., and Baggetto, L. G. Transcriptional regulators of the human multidrug resistance 1 gene: recent views. Biochem. Pharmacol., 64: 943-948, 2002. (Pubitemid 35232268)
51. Fryxell, K. B., McGee, S. B., Simoneaux, D. K., Willman, C. L., and Cornwell, M. M. Methylation analysis of the human multidrug resistance 1 gene in normal and leukemic hematopoietic cells. Leukemia, 13: 910-917, 1999. (Pubitemid 29292142)